Welcome Trust Clinical Research Facility
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chinoy, Hector
ALKIVIA, NCT05523167 / 2021-001277-23: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy.

Recruiting
2/3
240
Europe, Canada, Japan, US, RoW
EFG PH20 SC, PBO
argenx, argenx BV
Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome
12/26
02/27
MYOJAK, NCT04208464 / 2019-003868-42: JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM

Completed
2a
15
Europe
Baricitinib
University of Manchester, Eli Lilly and Company, Clinical Trials Unit, Manchester, Karolinska Institutet
Idiopathic Inflammatory Myopathies
09/23
09/23
MYOPROSP, NCT02468895: - a Prospective Cohort Study in Myositis

Active, not recruiting
N/A
300
Europe
University of Manchester, University of Bath, University College, London, Royal Victoria Infirmary, King's College Hospital NHS Trust, North Bristol NHS Trust, University of Liverpool, St. George's Hospital, London, Northern Care Alliance NHS Foundation Trust, Burton Hospitals NHS Foundation Trust, Doncaster And Bassetlaw Hospitals NHS Foundation Trust, Sandwell & West Birmingham Hospitals NHS Trust, London North West Healthcare NHS Trust, Nottingham University Hospitals NHS Trust, Sheffield Teaching Hospitals NHS Foundation Trust
Myositis, Idiopathic Inflammatory Myopathy
12/30
12/30

Download Options